So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...

John Bradley Sorenson, Executive Vice President of Global Operations at Boston Scientific Corp (NYSE:BSX), recently made significant transactions involving the company's stock. On February 12, ...

Boston Scientific’s Watchman LAAC helps reduce stroke risk in patients with a-fib and already contributes close to $1.5B in estimated annual revenue for Boston Scientific ($1.4B annualized in Q3 ...

Boston Scientific delivered another strong quarter, exceeding expectations in revenue and EPS. The company’s growth is underpinned by robust adoption of FARAPULSE and WATCHMAN, with significant ...

Boston Scientific (NYSE: BSX) shares ticked up slightly before hours today on fourth-quarter results that beat the consensus ...

Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...

The company states: “Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN FLX Left Atrial Appendage Closure Device ...

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Boston ...

Boston Scientific Corp (BSX) reports impressive Q4 2024 results with 22.4% revenue growth and a 26% increase in adjusted EPS, ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the irregular heartbeat known as atrial fibrillation—and the sum more than ...